Happify Health / Twill (DarioHealth)
DarioHealth (formerly Twill, formerly Happify Health)
Configurable digital therapeutics for pharma, health plans, and employers - now part of DarioHealth.
About Happify Health / Twill (DarioHealth)
Happify Health (rebranded to Twill in 2022, acquired by DarioHealth in 2024) offers configurable digital therapeutic solutions for mental health and chronic conditions. The platform's Sequences technology enables bespoke configurations of evidence-based digital therapeutics, wellbeing products, care communities, coaching, and third-party services for pharmaceutical companies, health plans, and large employers. Happify launched Ensemble, a prescription digital therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD), though it has not received FDA clearance. The company has partnerships with 3 of the 5 largest US health plans, over half of the top 20 global pharmaceutical companies (including Almirall, Biogen, and Elevance Health), and 3 of the 5 largest global tech companies. The DarioHealth acquisition in 2024 created one of the most comprehensive digital offerings for chronic conditions, with projected margins above 80% by 2025. The Happify consumer app has been available direct-to-consumer for over 10 years.
Best For
- • Pharmaceutical companies seeking digital companion therapies
- • Large health plans implementing digital mental health at scale
- • Global employers wanting evidence-based mental health solutions
- • Organizations needing customizable DTx configurations
Not Ideal For
- • Solo practitioners or small practices
- • Organizations seeking FDA-cleared products
- • Those needing traditional MBC assessment platforms
Pricing
Contact for enterprise pricing
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Get Started
Try Happify Health / Twill (DarioHealth) for your practice.
Visit Happify Health / Twill (DarioHealth)Related Tools
Koa Health
Clinical-first digital CBT platform with 7 DTx products backed by 21 clinical trials.
Woebot Health
Enterprise AI chatbot for mental health with FDA Breakthrough designation for postpartum depression.
Big Health (Sleepio, Daylight)
First FDA-cleared DTx for anxiety (DaylightRx) and insomnia (SleepioRx) with Medicare coverage.
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.